| 51 |
30572191 | Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin. | 2019 Feb 20 |
1 |
| 52 |
30638237 | Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel. | 2019 Feb 26 |
1 |
| 53 |
30650062 | MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer. | 2019 Mar |
1 |
| 54 |
30659778 | Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling. | 2019 Feb |
1 |
| 55 |
30959046 | Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. | 2019 Jun 5 |
2 |
| 56 |
31081816 | Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941. | 2019 Apr 28 |
1 |
| 57 |
31084979 | Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. | 2019 Jul |
1 |
| 58 |
31127007 | Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). | 2019 Aug |
1 |
| 59 |
31311995 | A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma. | 2019 Jul 16 |
1 |
| 60 |
31452210 | Cellular pharmacokinetics and pharmacodynamics mechanisms of ginkgo diterpene lactone and its modulation of P-glycoprotein expression in human SH-SY5Y cells. | 2019 Dec |
1 |
| 61 |
31506301 | Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban. | 2019 Nov |
2 |
| 62 |
31585733 | Testosterone and androstenedione are endogenous substrates of P-glycoprotein. | 2019 Nov 26 |
1 |
| 63 |
31810909 | Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells. | 2019 Dec |
2 |
| 64 |
28895074 | In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition. | 2018 Apr |
1 |
| 65 |
29174985 | Role of P-glycoprotein in deoxynivalenol-mediated in vitro toxicity. | 2018 Mar 1 |
1 |
| 66 |
29428540 | In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein. | 2018 May 30 |
2 |
| 67 |
29599328 | Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide. | 2018 Apr |
1 |
| 68 |
29635947 | An update on the clinical pharmacokinetics of fexofenadine enantiomers. | 2018 Apr |
1 |
| 69 |
30194155 | Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells. | 2018 Sep |
2 |
| 70 |
30350627 | A Monolayer of Primary Colonic Epithelium Generated on a Scaffold with a Gradient of Stiffness for Drug Transport Studies. | 2018 Nov 20 |
1 |
| 71 |
27504932 | Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation. | 2017 Aug |
1 |
| 72 |
27813130 | P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome Inhibitors. | 2017 May |
1 |
| 73 |
27883364 | Determination of S-methyl-L-methionine (SMM) from Brassicaceae Family Vegetables and Characterization of the Intestinal Transport of SMM by Caco-2 Cells. | 2017 Jan |
1 |
| 74 |
27926506 | Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar. | 2017 Jan 10 |
1 |
| 75 |
28028729 | Cardiovascular Ion Channel Inhibitor Drug-Drug Interactions with P-glycoprotein. | 2017 Mar |
1 |
| 76 |
28126516 | Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line. | 2017 Feb 15 |
1 |
| 77 |
28301084 | The Effect of Verapamil, a P-Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once-Daily JAK Inhibitor. | 2017 Nov |
2 |
| 78 |
28385544 | A Prediction Method for P-glycoprotein-Mediated Drug-Drug Interactions at the Human Blood-Brain Barrier From Blood Concentration-Time Profiles, Validated With PET Data. | 2017 Sep |
5 |
| 79 |
28389777 | Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists. | 2017 May |
1 |
| 80 |
28401570 | Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects. | 2017 Sep |
2 |
| 81 |
28421447 | Inhibition of P-glycoprotein stimulates cell death under Hypoxia-mimicking conditions. | 2017 Jan |
1 |
| 82 |
28528287 | Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. | 2017 Nov 15 |
3 |
| 83 |
28530401 | Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy. | 2017 Jun 14 |
1 |
| 84 |
28533092 | Thiol-reactive drug substrates of human P-glycoprotein label the same sites to activate ATPase activity in membranes or dodecyl maltoside detergent micelles. | 2017 Jul 8 |
1 |
| 85 |
28536971 | Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells. | 2017 Aug |
1 |
| 86 |
28560774 | Role of P-glycoprotein inhibitors in children with drug-resistant epilepsy. | 2017 Dec |
1 |
| 87 |
28669723 | The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. | 2017 Sep 2 |
1 |
| 88 |
28805879 | Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure. | 2017 Sep 20 |
1 |
| 89 |
28943850 | Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells. | 2017 |
3 |
| 90 |
29018094 | Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis. | 2017 Dec 15 |
2 |
| 91 |
29121121 | Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein. | 2017 |
1 |
| 92 |
29187454 | P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression. | 2017 Dec |
1 |
| 93 |
29299132 | Saikosaponins A, C and D enhance liver-targeting effects of anticancer drugs by modulating drug transporters. | 2017 Dec 15 |
1 |
| 94 |
29521222 | Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines. | 2017 |
3 |
| 95 |
30108713 | Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis. | 2017 Oct 1 |
1 |
| 96 |
26514967 | Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. | 2016 Feb |
2 |
| 97 |
26565618 | Oligomycins as inhibitors of K-Ras plasma membrane localisation. | 2016 Jan 14 |
1 |
| 98 |
26585254 | Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy. | 2016 Apr |
1 |
| 99 |
26823559 | Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein. | 2016 Jan 28 |
7 |
| 100 |
26836364 | Optimization by Molecular Fine Tuning of Dihydro-β-agarofuran Sesquiterpenoids as Reversers of P-Glycoprotein-Mediated Multidrug Resistance. | 2016 Mar 10 |
1 |